Thank you. So, currently, 340B discounts are provided at the point of purchase. However, Pharmaceutical manufacturers have tried to implement rebate models in the [340B] program. and the Health Resources and Services Administration has proposed a rebate model pilot program that would go into effect on January 1st. (00:08–00:15)
CLAIM
Asserts that pharmaceutical manufacturers are attempting to change the 340B program to a rebate model.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.